CTSO
Cytosorbents Corporation (CTSO)
$13
About Cytosorbents Corporation (CTSO)
CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin in August 1997 and is headquartered in Princeton, NJ.
Details
Daily high
$1.18
Daily low
$1.10
Price at open
$1.16
52 Week High
$2.15
52 Week Low
$0.70
Market cap
61.5M
Dividend yield
0.00%
Volume
78,584
Avg. volume
123,302
P/E ratio
-2.17
Cytosorbents Corporation News
Details
Daily high
$1.18
Daily low
$1.10
Price at open
$1.16
52 Week High
$2.15
52 Week Low
$0.70
Market cap
61.5M
Dividend yield
0.00%
Volume
78,584
Avg. volume
123,302
P/E ratio
-2.17